Concepedia

Diana Giannarelli

DG

Statistics

Publications

355

Citations

19.9K

H-Index

69

Active since

1984

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Sapienza University of Rome

National Cancer Institute

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Diana Giannarelli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1984–2025

355

Publications

355

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

Pierluigi Benedetti Panici, S. Basile, F. Maneschi et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.5K citations · Full text

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Mariaelena Capone, Diana Giannarelli, Domenico Mallardo et al. · Journal for ImmunoTherapy of Cancer · 2018 · 499 citations · Full text

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

Pier Francesco Ferrucci, Paolo A. Ascierto, Jacopo Pigozzo et al. · Annals of Oncology · 2016 · 389 citations · Full text

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

Antonio Maria Grimaldi, Ester Simeone, Diana Giannarelli et al. · OncoImmunology · 2014 · 370 citations · Full text

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Luana Calabrò, Aldo Morra, Ester Fonsatti et al. · The Lancet Oncology · 2013 · 353 citations

, , +5

1–5 of 355